NasdaqGS - Delayed Quote USD
4D Molecular Therapeutics, Inc. (FDMT)
At close: October 22 at 4:00 PM EDT
After hours: October 22 at 6:47 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
-85,152.00
-75,792.00
-86,685.00
-69,134.00
-50,909.00
--
Investing Cash Flow
-313,498.00
115,717.00
-17,050.00
-172,680.00
-1,000.00
--
Financing Cash Flow
351,400.00
156,832.00
3,085.00
118,089.00
278,983.00
--
End Cash Position
189,061.00
249,108.00
52,351.00
153,001.00
276,726.00
--
Capital Expenditure
-2,013.00
-2,771.00
-11,536.00
-9,110.00
-1,000.00
--
Issuance of Capital Stock
340,388.00
148,344.00
--
114,296.00
278,126.00
--
Repurchase of Capital Stock
--
--
--
--
--
-2,270.00
Free Cash Flow
-87,165.00
-78,563.00
-98,221.00
-78,244.00
-51,909.00
--
12/31/2019 - 12/11/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ADVM Adverum Biotechnologies, Inc.
8.14
-1.45%
OCUL Ocular Therapeutix, Inc.
11.30
-0.62%
CGEM Cullinan Therapeutics, Inc.
15.95
-1.54%
EYPT EyePoint Pharmaceuticals, Inc.
10.75
+0.47%
STOK Stoke Therapeutics, Inc.
12.52
-0.48%
RGNX REGENXBIO Inc.
9.59
-7.52%
CABA Cabaletta Bio, Inc.
4.2900
-5.09%
MGTX MeiraGTx Holdings plc
5.98
-0.17%
ZNTL Zentalis Pharmaceuticals, Inc.
3.1200
-2.50%
LXEO Lexeo Therapeutics, Inc.
10.07
-4.28%